Blood Collection Market

Apheresis is a process that can be used to later on separate blood into its various components after it has been initially collected as whole blood (WB) during the process of blood donation. The amount of blood that is extracted varies, but it should never be more than one percent of the donor's total body weight.

The global Blood Collection market worth $ 7460 Million by 2030, growing at a CAGR of 6.8%

Covid-19 Impact

The global COVID-19 epidemic poses a substantial public health threat and is projected to significantly affect the blood collection market. Each test is being evaluated by both hospital and independent labs to see if consultations with laboratory informatics hematologists should be suggested for tests with a higher risk profile or whether the test should be withheld altogether if it cannot be conducted safely. In the early months of the pandemic, this had a detrimental impact on the market, leading to a decrease in the demand for blood collection instruments. Later on, however, the market is expected to expand thanks to rising concerns, higher testing volumes, and the necessity of routine health and body checks.

North America will dominate the Blood Collection Market

In 2021, North America was responsible for 30.3% of the revenue that was generated in the worldwide market, with the United States being the country that contributed the greatest proportion of its overall revenue to the market. Increasing healthcare research activities, robust presence of major clinical sepsis diagnostics businesses, and rising rates of sophisticated instrument and diagnostic technique adoption are some of the key factors driving revenue growth of the market in this region.

Asia-Pacific will see a stable growth rate in the period of interest

An expanding number of blood donation programs and rapid advancements in healthcare infrastructure are two of the primary reasons that are driving revenue growth of the market in this sector.

Needle Segment will dominate the Blood Collection Market

In the global market in the year 2021, the biggest revenue share was accounted for by needles. This market segment's revenue growth is being driven in large part by several factors, including its relatively low price point, its high rate of repeat purchases, and its increasing simplicity of use.

The collection of blood can either be done with the assistance of automated equipment that collects only certain components of blood, or it can be done manually. Either way, it is possible.

Keeping whole blood samples frozen and transporting them presents a number of substantial obstacles and expenses. After it has been obtained, whole blood either needs to be utilized right away or preserved and maintained under very specific temperature and environmental conditions so that it can be used for analysis or some other purpose. 

If the blood samples are not chilled or frozen immediately after collection, the features of the blood will begin to change within a few hours. Because blood components begin to deteriorate almost instantly, it is necessary to keep them in a stable state; prolonged exposure to ambient temperatures can significantly impact the results of any analysis performed on such samples. Because of this, medical organizations from all around the world have come up with recommendations for the storing, packaging, and smart transportation of these items.

It might be tricky or even impossible to obtain blood samples from people who have a difficult time gaining access to their veins. In patients with DVA, the blood collection products that are conventionally utilized are frequently unable to collect appropriate samples. This can also lead to repeated attempts to draw blood from the patient.

This raises the likelihood that patients will get anemia and the likelihood that nurses and phlebotomists may become infected with blood-borne diseases. Innovative hematology tube designs have been designed to enable capillary blood collection in DVA patients, with the goal of lowering the risks of collection and processing errors in these patients. Because the gadget uses ultrasound or infrared technology to illuminate the veins beneath the skin and infrared technology to allow easy vein access, it makes it possible to reduce the number of times that venipuncture needs to be performed.

In the market for blood collection equipment, one significant trend that is quickly gaining popularity is the advancement of technology. A significant number of businesses currently active in the blood collection devices market are producing new items or new technologies in order to satisfy the rapidly expanding industry demand and strengthen their commercial presence in regions all over the world. The technologically advanced items that are developed by corporations are centered on the goal of improving consumers' levels of comfort and providing them with increased levels of protection.

The companies Kabe Labortechnik GmbH, Greiner Group, Terumo Corporation, Fresenius Kabi, Medtronic, Dickinson and Company, Sarstedt AG & Company, Retractable Technologies, ICU Medical Inc, Radiometer Medical ApS, Nipro Corporation, Becton, and Grifols SA are the major players in the market for blood collection.

Recent Developments in the Global Blood Collection Market: a Snapshot

• When Becton, Dickinson and Company (BD), a global leader in medical technology, bought Velano Vascular in July 2021, the terms of the deal were not disclosed. By acquiring this company, BD is able to assist healthcare practitioners in eliminating the need for several needlesticks during blood sample collection, thereby lowering patient pain and discomfort and enhancing patient satisfaction. American company Velano Vascular focuses on improving in-hospital blood collection and vascular access.

Blood Collection Market Scope

Key segments in the Global Blood Collection Market

Type Overview (USD Million)

• Lancets
• Bags
• Vials
• Needles
• Syringes
• Tubes
• Others

End-User Overview, (USD Million)

• Diagnostic Centers
• Blood Banks
• Hospitals
• Others

Application Overview,  (USD Million)

• Diagnosis
• Treatment

Regional Overview,  (USD Million)

• North America
  • United States of America
  • Canada
  • Mexico
• Europe
  • France
  • Germany
  • Italy
  • the Netherlands
  • Poland
  • Russia
  • The United Kingdom
  • Rest of Europe
• Asia-Pacific
  • China
  • India
  • Indonesia
  • South Korea
  • Rest of Asia-Pacific
• South America
  • Argentina
  • Brazil
  • Peru
  • Uruguay
  • Rest of South America